Heart failure and edema due to the use of non-steroidal anti-inflammatory drugs;Hartfalen en vochtretentie toegeschreven aan het gebruik van niet-steroide anti-inflammatoire geneesmiddelen

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 40, 1996, Pages 2000-2003

  Feenstra, J ^a   Stricker, B H Ch ^a,b  

^a Sectie Geneesmiddelenbewaking   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE;

AGED; ARTICLE; CASE REPORT; EDEMA; FEMALE; HEART FAILURE; HUMAN; MALE; PAIN;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; EDEMA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSTAGLANDINS;

EID: 0029823546     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Leufkens HGM. Pharmacy records in pharmacoepidemiology studies on antiinflammatory and antirheumatic drugs [proefschrift]. Utrecht Rijksuniversiteit Utrecht, 1990.
2. Ouweland FA van den. Gribnau FW, Meyboom RH. Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly. Age Ageing 1988;17:8-16.
3. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988,148:2013-6.
4. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971,285.1441-6.
5. Stricker BHCh. Bijwerkingen van geneesmiddelen: de causaliteitsbeoordeling. Ned Tijdschr Geneeskd 1989;133:275-80.
6. Reitsma JB, Mosterd A, Koster RW, Capelle FJL van, Grobbee DE, Tijssen JGP Stijging van het aantal opnamen wegens hartfalen in Nederlandse ziekenhuizen m de periode 1980-1992. Ned Tijdschr Geneeskd 1994;138.866-71.
7. Gillura RF. Heart failure in the United States 1970-1985. Am Heart J 1987;113.1043-5.
8. Mosterd A, Reitsma JB, Ottervanger JP, Deckers JW, Tijssen JGP, Grobbee DE. Epidemiologie van hartfalen. Hart Bulletin 1993; 24:245-51.
9. Nevins M, Berque S, Corwin N, Lyon L. Phenylbutazone and pulmonary oedema. Lancet 1969;11:1358.
10. Schooley RT, Wagley PF, Lietman PS. Edema associated with ibuprofen therapy. JAMA 1977;237:1716-7.
11. Tashima CK, Rose M. Pulmonary edema and salicylates. Ann Intern Med 1974;81:274-5
12. Coles LS, Fries JF, Kraines RG, Roth SH. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med 1983;74:820-8
13. Ziekenfondsraad. Farmacotherapeutisch kompas. Amstelveen: Centrale Medisch Pharmaceutische Commissie van de Ziekenfondsraad, 1996.
14. Heerdink ER. Clustering of drugs use in the elderly population based studies into prevalence and outcomes [proefschrift]. Utrecht: Rijksuniversiteit Utrecht, 1995.
15. Appleton I, Tomlinson A, Willoughby DA. Inducible cyclooxygenase (COX-2): a safer therapeutic target? Br J Rheumatol 1994: 33:410-2.
16. Cannon PJ. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs. Am J Med 1986;81:123-32.
17. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-52.
18. Harris K. The role of prostaglandins in the control of renal function. Br J Anaesth 1992;69:233-5.
19. Rabelink TJ, Koomans HA, Dorhout Mees EJ. Role of prostaglandins in the natriuresis of head-out water immersion in humans. Clin Sci (Colch) 1991;80:481-8.
20. Passmore AP, Copeland S, Johnston GD. The effects of ibuprofen and indomethacin on renal function in the presence and absence of frusemide in healthy volunteers on a restricted sodium diet. Br J Clin Pharmacol 1990;29:311-9.
21. Koopmans PP. Pathophysiological and clinical aspects of the interaction between non-steroidal anti-inflammatory drugs (NSAID) and diuretics. Neth J Med 1985;28:524-9.
22. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-72.
23. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 1993;44:643-53.
24. Friedman PL, Brown jr E, Gunther S, Alexander RW, Barry WH, Mudge jr GH, et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med 1981;305: 1171-5.
25. Blackshear JL, Davidman M, Stillman MT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983;143 1130-4